BSECompany Update1d ago · 28 Oct 2026, 03:07 pm
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 to be held on 03rd and 4th November, 2026.
Concord Biotech Ltd · 543960
✦ AI Summary
Concord Biotech Ltd has announced its schedule of analyst/institutional investor meetings under SEBI regulations, to be held on 3rd and 4th November 2026 in Singapore.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation